Related Experiment Video
Updated: Jul 28, 2026
13:54
Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
11.0K
Knocking down GRAMD1C expression reduces 6-OHDA-induced apoptosis in PC12 cells
Hui He1, Bo Zhang1, Xiang Wang2
1Department of Nursing, Health Higher Vocational and Technical School of Nantong, No. 288 revitalizing East Road, Nantong Economic Development Zone, Nantong, 226010, China.
Toxicology Research
|April 19, 2024
Summary
GRAMD1C gene expression is elevated in Parkinson's disease (PD). Reducing GRAMD1C levels in cells helps restore proliferation and reduce apoptosis, suggesting its role in PD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with complex genetic underpinnings.
- Identifying novel genes and pathways involved in PD pathogenesis is crucial for therapeutic development.
Purpose of the Study:
- To identify differentially expressed genes in Parkinson's disease using bioinformatics.
- To investigate the role of GRAMD1C in PD pathogenesis and its potential mechanisms.
Main Methods:
- Bioinformatic analysis of GEO database for differentially expressed genes (DEGs) in PD.
- KEGG and GO analyses to predict signaling pathways and molecular functions.
- In vitro study using 6-hydroxydopamine (6-OHDA) induced PC12 cell model to assess GRAMD1C function.
Main Results:
- GRAMD1C was identified as a significantly upregulated gene in PD patients and 6-OHDA-induced cells.
- GRAMD1C knockdown reversed 6-OHDA-induced reduction in PC12 cell proliferation.
- Knockdown of GRAMD1C reduced apoptosis and modulated apoptosis-related proteins (Bax, Caspase-3, Bcl-2) in 6-OHDA-treated cells.
Conclusions:
- GRAMD1C is upregulated in Parkinson's disease.
- GRAMD1C plays a role in PD pathogenesis, potentially through the regulation of apoptotic pathways.
